Integrated Diagnostics Holdings plc (LON: IDHC)

Market Cap	205.56M
Revenue (ttm)	78.23M
Net Income (ttm)	13.46M
Shares Out	581.33M
EPS (ttm)	0.02
PE Ratio	15.36
Forward PE	13.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,435
Average Volume	51,690
Open	0.421
Previous Close	0.436
Day's Range	0.420 - 0.430
52-Week Range	0.275 - 0.540
Beta	0.48
RSI	43.49
Earnings Date	Apr 3, 2025

About LON: IDHC

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography – computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,692
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2023, IDHC's revenue was 4.12 billion, an increase of 14.35% compared to the previous year's 3.61 billion. Earnings were 510.30 million, a decrease of -5.69%.

Financial numbers in EGP